Breaking News
Investing Pro 0
🚨 NDVA surged 43%. This AI Chipmaker Could Be Next See Analysis

What you need to know about the coronavirus right now

Published Apr 06, 2021 15:30 Updated Apr 08, 2021 15:12
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
 
AZN
-0.03%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
AZN
+1.28%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

April 8 (Reuters) - Here's what you need to know about the coronavirus right now:

NZ temporarily suspends entry to travellers from India

New Zealand on Thursday temporarily suspended entry for all travellers from India, including its own citizens, for about two weeks following a high number of positive coronavirus cases arriving from the South Asian country.

The move comes after New Zealand recorded 23 new positive coronavirus cases at its border on Thursday, of which 17 were from India. The suspension will start from 1600 local time on April 11 and will be in place until April 28. rollout to continue in Australia

Australia has no current plans to change the rollout of the AstraZeneca (NASDAQ:AZN) COVID-19 vaccine, Prime Minister Scott Morrison said on Thursday, after Europe's drug regulator found possible links between rare blood clots and the vaccine.

Australian authorities have ordered an urgent inquiry into findings from Europe's drug regulator with Morrison expecting updates later on Thursday from the medicines regulator and the immunisation advisory group. guidance in the EU on AstraZeneca shot

European Union health ministers failed on Wednesday to agree a common guidance on the use of the AstraZeneca COVID-19 vaccine, despite calls for coordination across member states to combat public hesitancy over taking the shot. and Spain recommended on Wednesday that it only be used on those over 60 and Britain that people under 30 should get an alternative, due to possible links between the vaccine and very rare cases of blood clots. approved by EU, Germany wants to buy Sputnik vaccine

Germany is about to start bilateral negotiations with Russia to obtain its Sputnik V COVID-19 vaccine, a source told Reuters on Wednesday, adding that any final agreement depended on Russia providing key data to the European Medicines Agency (EMA). In the preliminary talks, Germany first wants to determine which quantities Russia can deliver and when, the source said.

In any case, Germany will only buy the Russian vaccine once it has been approved by EMA and for this it is paramount that Russia provides the necessary data, the source added. detecting UK variant, Thailand braces for infections

Thailand has detected at least 24 cases of the coronavirus variant B.1.1.7 first identified in Britain, a government health expert said on Wednesday, its first known domestic transmission of the highly contagious variant. The UK variant was found in a cluster of 24 visitors to entertainment venues in Bangkok, which were detected at the weekend. Nearly 200 such venues have been closed for two weeks.

Thai Prime Minister Prayuth Chan-ocha instructed authorities to prepare field hospitals in anticipation of a spike in infections. Ten of his ministers and dozens of lawmakers were self-isolating on Wednesday due to exposure to positive cases.

What you need to know about the coronavirus right now
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email